Prenatal corticosterone exposure results in altered AT1/AT2, nephron deficit and hypertension in the rat offspring

Journal of Physiology

Volumn 579, Issue 2, 2007, Pages 503-513

  Singh, Reetu R ^a   Cullen McEwen, Luise A ^a   Kett, Michelle M ^b   Boon, Wee Ming ^b   Dowling, John ^a   Bertram, John F ^a   Moritz, Karen M ^a  

^a MONASH UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; CORTICOSTERONE; GLUCOCORTICOID; ANGIOTENSIN 1A RECEPTOR;

ADOLESCENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CELL COUNT; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DOWN REGULATION; FEMALE; GESTATIONAL AGE; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NEPHRON; NONHUMAN; PATHOGENESIS; PERINATAL PERIOD; PHENOTYPE; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEX DIFFERENCE; STEREOLOGY; STRESS; ANIMAL CELL; AT1RA GENE; AT1RB GENE; AT2R GENE; BODY WEIGHT; EMBRYO; GENE; GENE EXPRESSION; HEART RATE; KIDNEY MASS; PLASMA RENIN ACTIVITY; PRENATAL DRUG EXPOSURE; UPREGULATION;

ANIMALS; BLOOD PRESSURE; CORTICOSTERONE; FEMALE; FETAL DEVELOPMENT; GENE EXPRESSION REGULATION; HEART RATE; HUMANS; HYPERTENSION; MALE; NEPHRONS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RENIN; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER;

EID: 33847679962     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2006.125773     Document Type: Article

References (45)

1. Barker D (1999). Fetal origins of cardiovascular disease. Ann Med 31, 3-6.
2. Barker D (2002). Fetal programming of coronary heart disease. Trends Endocrinol Metab 13, 364-368.
3. Barker D (2003). The developmental origins of adult disease. Eur J Epidemiol 18, 733-736.
4. Barker D, Gluckman P, Godfrey K, Harding J, Owens J & Robinson J (1993). Fetal undernutrition and cardiovascular disease in adult life. Lancet 341, 938-941.
5. Barker D & Osmond C (1986). Infant mortality, childhood undernutrition, and ischemic heart disease in England and Wales. Lancet I, 1077-1081.
6. Bergstrom G, Johansson I, Stevenson KM, Kett MM & Anderson WP (1998). Perindopril treatment affects both preglomerular renal vascular lumen dimensions and in vivo responsiveness to vasoconstrictors in spontaneously hypertensive rats. Hypertension 31, 1007-1013.
7. Bertram J, Soosaipillai M, Ricardo S & Ryan G (1992). Total numbers of glomeruli and individual glomerular cell types in the normal rat kidney. Cell Tissue Res 270, 37-45.
8. Brenner B, Garcia D & Anderson S (1988). Glomeruli and blood pressure. Less one, more the other? Am J Hypertension 1, 335-347.
9. Coles H, Burne J & Raff M (1993). Large scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development 118, 777-784.
10. Cullen-McEwen LA, Kett MM, Dowling J, Anderson WP & Bertram JF (2003). Nephron number, renal function, and arterial pressure in aged GDNF heterozygous mice. Hypertension 41, 335-340.
11. Dodic M, Abouantoun T, O'Connor A, Wintour E & Moritz K (2002 a). Programming effects of short prenatal exposure to dexamethasone in sheep. Hypertension 40, 729-734.
12. Dodic M, Hantzis V, Duncan J, Rees S, Koukoulas I, Johnson K, Wintour E & Moritz K (2002 b). Programming effects of short prenatal exposure to cortisol. FASEB J 16, 1017-1026.
13. Dodic M, May C, Wintour E & Coghlan J (1998). An early prenatal exposure to excess glucocorticoid leads to hypertensive offspring in sheep. Clin Sci (Lond) 94, 149-155.
14. Dodic M, Peers A, Coghlan J, May C, Lumbers E, Yu Z & Wintour E (1999). Altered cardiovascular haemodynamics and baroreceptor-heart rate reflex in adult sheep after prenatal exposure to dexamethasone. Clin Sci (Lond) 97, 103-109.
15. Giordano M, Vermeulen M, Trevani A, Dran G, Andonegui G & Geffner J (1996). Nitric oxide synthase inhibitors enhance plasma levels of corticosterone and ACTH. Acta Physiol Scand 157, 259-264.
16. Graciano M, Cavaglieri R, Delle H, Dominguez W, Casarini D, Malheiros D & Noronha I (2004). Intra renin-angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis. J Am Soc Nephrol 15, 1805-1815.
17. Gundersen H, Bendtsen T, Korbo L, Marcussen N, Moller A, Nielsen K, Nyengaard J, Pakkenberg B, Sorensen F & Vesterby A (1988). Some new, simple and efficient stereological methods and their use in pathological and diagnosis. APMIS 96, 379-394.
18. Keller G, Zimmer G, Mall G, Ritz E & Amann K (2003). Nephron number in patients with primary hypertension. N Engl J Med 348, 101-108.
19. Kett M, Alcorn D, Bertram J & Anderson W (1996). Glomerular dimensions in spontaneously hypertensive rats: Effects of AT1 antagonism. J Hypertension 14, 107-113.
20. Kett MM, Denton KM, Boesen EI & Anderson WP (2004). Effects of early carvedilol treatment and withdrawal on the development of hypertension and renal vascular narrowing. Am J Hypertension 17, 161.
21. Langley-Evans SC (1997). Maternal carbenoxolone treatment lowers birthweight and induces hypertension in the offspring of rats fed a protein-replete diet. Clin Sci 93, 423-429.
22. Lindsay R, Lindsay R, Edwards C & Seckl J (1996). Inhibition of 11-beta-hydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring. Hypertension 6, 1200-1204.
23. McMullen S & Langley-Evans SC (2005). Maternal low-protein diet in rat pregnancy programs blood pressure through sex-specific mechanisms. Am J Physiol Regul Integr Comp Physiol 288, R85-R90.
24. Merlet-Benichou C, Gilbert T & Muffat-Joly M (1994). Intrauterine growth retardation leads to a permanent nephron deficit in the rat. Pediatr Nephrol 8, 175-180.
25. Michael AE, Thurston LM & Rae MT (2003). Glucocorticoid metabolism and reproduction: A tale of two enzymes. Reproduction 126, 425-441.
26. Moritz K, Jefferies A, Douglas-Denton R, Wintour E & Dodic M (2004). Reduced nephron number in the late gestation fetus after early maternal glucocorticoid treatment. Ninth International Workshop on Developmental Nephrology, Barossa Valley, Australia, September, 2004.
27. Moritz K, Johnson K, Douglas-Denton R, Wintour E & Dodic M (2002 a). Maternal glucocorticoid treatment programs alterations in the rennin-angiotensin system of the ovine fetal kidney. Endocrinology 143, 4455-4463.
28. Moritz KM, Johnson K, Douglas-Denton R, Wintour EM & Dodic M (2002 b). Maternal glucocorticoid treatment programs alterations in the rennin-angiotensin system of the ovine fetal kidney. Endocrinology 143, 4455-4463.
29. Moritz K & Wintour E (1999). Functional development of the meso-metanephros. Pediatr Nephrol 13, 171-178.
30. Nussberger J, Brunner D, BW & Brunner H (1985). True versus immunoreactive angiotensin II in human plasma. Hypertension 7 (suppl. 1), I1-I7.
31. 1B receptors for angiotensin II. Proc Natl Acad Sci U S A 95, 15496-15501.
32. Ortiz L, Quan A, Weinberg A & Baum M (2001). Effect of prenatal dexamethasone on rat renal development. Kidney Int 59, 1663-1669.
33. Ortiz L, Quan A, Zarzar F, Weinberg A & Baum M (2003). Prenatal dexamethasone programs hypertension and renal injury in the rat. Hypertension 41, 328-334.
34. Seckl JR (1997). Glucocorticoids, feto-placental 11[beta]-hydroxysteroid dehydrogenase type 2, and the early life origins of adult disease. Steroids 62, 89.
35. Stevenson KM, Edgley AJ, Bergstrom G, Worthy K, Kett MM & Anderson WP (2000). Angiotensin II infused intrarenally causes preglomerular vascular changes and hypertension. Hypertension 36, 839-844.
36. Tufro-McReddie A, Romano LM, Harris JM, Ferder L & Gomez RA (1995). Angiotensin II regulates nephrogenesis and renal vascular development. Am J Physiol Renal Physiol 269, F110-F115.
37. Vehaskari VM, Stewart T, Lafont D, Soyez C, Seth D & Manning J (2004). Kidney angiotensin and angiotensin receptor expression in prenatally programmed hypertension. Am J Physiol Renal Physiol 287, F262-F267.
38. Vize P, Seufert D, Carroll T & Wallingford J (1997). Model systems for the study of kidney develpment: Analysis of organ induction and patterning. Dev Biol 188, 189-204.
39. Welham SJM, Riley PR, Wade A, Hubank M & Woolf AS (2005). Maternal diet programs embryonic kidney gene expression. Physiol Genomics 22, 48-56.
40. Welham S, Wade A & Woolf A (2002). Protein restriction in pregnancy is associated with increased apoptosis of mesenchymal cells at the start of rat metanephrogenesis. Kidney Int 61, 1231-1242.
41. Wintour E, Dodic M, Matteo RD, McAlinden A, Jefferies A, Bartal D & Moritz K (2005). Glucocorticoids and programming: Evidence for different effects depending on the steroid used. Pediatr Res 58, 1078.
42. Wintour E, Moritz K, Johnson K, Ricardo S, Samuel C & Dodic M (2003). Reduced nephron number in adult sheep, hypertensive as a result of prenatal glucocorticoid treatment. J Physiol 549, 929-935.
43. Woods LL, Ingelfinger JR, Nyengaard JR & Rasch R (2001). Maternal protein restriction suppresses the newborn renin-angiotensin system and programs adult hypertension in rats. Pediatr Res 49, 460-467.
44. Woods LL & Rasch R (1998). Perinatal ANG II programs adult blood pressure, glomerular number, and renal function in rats. Am J Physiol Regul Integr Comp Physiol 275, R1593-R1599.
45. Woods LL, Weeks DA & Rasch R (2004). Programming of adult blood pressure by maternal protein restriction: Role of nephrogenesis. Kidney Int 65, 1339-1348.